| List Name |
Annotation |
Enrichment |
p-value |
| regulation of interleukin-6 biosynthetic process |
AmiGO Browser |
75.85 |
6.64e-06 |
| interleukin-6 biosynthetic process |
AmiGO Browser |
60.68 |
1.41e-05 |
| interleukin-6 production |
AmiGO Browser |
60.68 |
1.41e-05 |
| B cell activation |
AmiGO Browser |
8.79 |
2.89e-04 |
| somatic recombination of immunoglobulin genes during immune response |
AmiGO Browser |
20.23 |
4.44e-04 |
| isotype switching |
AmiGO Browser |
20.23 |
4.44e-04 |
| somatic diversification of immunoglobulins during immune response |
AmiGO Browser |
20.23 |
4.44e-04 |
| immunoglobulin production during immune response |
AmiGO Browser |
20.23 |
4.44e-04 |
| somatic cell DNA recombination |
AmiGO Browser |
19.57 |
4.90e-04 |
| somatic diversification of immune receptors via germline recombination within a single locus |
AmiGO Browser |
19.57 |
4.90e-04 |
| somatic recombination of immunoglobulin gene segments |
AmiGO Browser |
19.57 |
4.90e-04 |
| positive regulation of interleukin-6 biosynthetic process |
AmiGO Browser |
57.79 |
5.05e-04 |
| somatic diversification of immunoglobulins |
AmiGO Browser |
17.85 |
6.45e-04 |
| somatic diversification of immune receptors |
AmiGO Browser |
17.85 |
6.45e-04 |
| regulation of chemokine biosynthetic process |
AmiGO Browser |
50.57 |
6.71e-04 |
| chemokine metabolic process |
AmiGO Browser |
44.95 |
8.60e-04 |
| chemokine biosynthetic process |
AmiGO Browser |
44.95 |
8.60e-04 |
| chemokine production |
AmiGO Browser |
44.95 |
8.60e-04 |
| immunoglobulin production |
AmiGO Browser |
15.56 |
9.67e-04 |
| cytokine production |
AmiGO Browser |
6.61 |
1.05e-03 |
| positive regulation of B cell proliferation |
AmiGO Browser |
40.45 |
1.07e-03 |
| negative regulation of NF-kappaB import into nucleus |
AmiGO Browser |
36.78 |
1.31e-03 |
| acute-phase response |
AmiGO Browser |
13.79 |
1.38e-03 |
| thermoregulation |
AmiGO Browser |
33.71 |
1.56e-03 |
| cytoplasmic sequestering of transcription factor |
AmiGO Browser |
31.12 |
1.84e-03 |
| cytoplasmic sequestering of protein |
AmiGO Browser |
31.12 |
1.84e-03 |
| immune system development |
AmiGO Browser |
4.09 |
1.87e-03 |
| insulin receptor signaling pathway |
AmiGO Browser |
11.90 |
2.11e-03 |
| production of molecular mediator of immune response |
AmiGO Browser |
11.90 |
2.11e-03 |
| negative regulation of transcription factor import into nucleus |
AmiGO Browser |
25.28 |
2.80e-03 |
| negative regulation of protein import into nucleus |
AmiGO Browser |
25.28 |
2.80e-03 |
| regulation of B cell proliferation |
AmiGO Browser |
25.28 |
2.80e-03 |
| B cell differentiation |
AmiGO Browser |
10.65 |
2.90e-03 |
| negative regulation of protein transport |
AmiGO Browser |
23.80 |
3.16e-03 |
| negative regulation of nucleocytoplasmic transport |
AmiGO Browser |
23.80 |
3.16e-03 |
| adrenal gland development |
AmiGO Browser |
22.47 |
3.55e-03 |
| regulation of isotype switching |
AmiGO Browser |
22.47 |
3.55e-03 |
| regulation of transcription, DNA-dependent |
AmiGO Browser |
1.85 |
4.41e-03 |
| regulation of transforming growth factor beta receptor signaling pathway |
AmiGO Browser |
19.26 |
4.82e-03 |
| response to metal ion |
AmiGO Browser |
19.26 |
4.82e-03 |
| response to external stimulus |
AmiGO Browser |
2.66 |
5.21e-03 |
| NF-kappaB import into nucleus |
AmiGO Browser |
18.39 |
5.29e-03 |
| regulation of NF-kappaB import into nucleus |
AmiGO Browser |
18.39 |
5.29e-03 |
| regulation of actin filament length |
AmiGO Browser |
8.31 |
5.81e-03 |
| regulation of cellular metabolic process |
AmiGO Browser |
1.73 |
6.23e-03 |
| transcription, DNA-dependent |
AmiGO Browser |
1.80 |
6.26e-03 |
| neutrophil chemotaxis |
AmiGO Browser |
16.86 |
6.28e-03 |
| determination of left/right symmetry |
AmiGO Browser |
16.86 |
6.28e-03 |
| RNA biosynthetic process |
AmiGO Browser |
1.80 |
6.34e-03 |
| central nervous system development |
AmiGO Browser |
3.66 |
6.64e-03 |
| positive regulation of B cell activation |
AmiGO Browser |
16.18 |
6.80e-03 |
| immunoglobulin mediated immune response |
AmiGO Browser |
7.68 |
7.22e-03 |
| B cell mediated immunity |
AmiGO Browser |
7.68 |
7.22e-03 |
| determination of symmetry |
AmiGO Browser |
15.56 |
7.34e-03 |
| determination of bilateral symmetry |
AmiGO Browser |
15.56 |
7.34e-03 |
| regulation of signal transduction |
AmiGO Browser |
2.67 |
7.72e-03 |
| B cell proliferation |
AmiGO Browser |
14.98 |
7.90e-03 |
| negative regulation of myeloid cell differentiation |
AmiGO Browser |
14.98 |
7.90e-03 |
| response to inorganic substance |
AmiGO Browser |
14.98 |
7.90e-03 |
| signal transduction |
AmiGO Browser |
1.59 |
8.00e-03 |
| regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process |
AmiGO Browser |
1.73 |
8.14e-03 |
| DNA recombination |
AmiGO Browser |
5.12 |
8.18e-03 |
| regulation of cytokine biosynthetic process |
AmiGO Browser |
7.14 |
8.83e-03 |
| regulation of transcription from RNA polymerase II promoter |
AmiGO Browser |
2.60 |
9.13e-03 |
| regulation of transcription |
AmiGO Browser |
1.72 |
0.01 |
| negative regulation of cell differentiation |
AmiGO Browser |
6.74 |
0.01 |
| regulation of metabolic process |
AmiGO Browser |
1.65 |
0.01 |
| regulation of transcription factor import into nucleus |
AmiGO Browser |
12.64 |
0.01 |
| leukocyte chemotaxis |
AmiGO Browser |
12.64 |
0.01 |
| transcription factor import into nucleus |
AmiGO Browser |
12.64 |
0.01 |
| lymphocyte activation |
AmiGO Browser |
3.76 |
0.01 |
| positive regulation of progression through cell cycle |
AmiGO Browser |
12.26 |
0.01 |
| negative regulation of transport |
AmiGO Browser |
12.26 |
0.01 |
| maintenance of cellular protein localization |
AmiGO Browser |
12.26 |
0.01 |
| transcription from RNA polymerase II promoter |
AmiGO Browser |
2.23 |
0.01 |
| acute inflammatory response |
AmiGO Browser |
6.32 |
0.01 |
| regulation of intracellular protein transport |
AmiGO Browser |
11.90 |
0.01 |
| regulation of protein import into nucleus |
AmiGO Browser |
11.90 |
0.01 |
| circadian rhythm |
AmiGO Browser |
11.90 |
0.01 |
| maintenance of protein localization |
AmiGO Browser |
11.90 |
0.01 |
| immune system process |
AmiGO Browser |
2.14 |
0.01 |
| regulation of cellular process |
AmiGO Browser |
1.48 |
0.01 |
| cytokine biosynthetic process |
AmiGO Browser |
6.13 |
0.01 |
| brain development |
AmiGO Browser |
4.42 |
0.01 |
| cytokine metabolic process |
AmiGO Browser |
6.07 |
0.01 |
| maintenance of cellular localization |
AmiGO Browser |
11.24 |
0.01 |
| cell proliferation |
AmiGO Browser |
2.10 |
0.01 |
| regulation of intracellular transport |
AmiGO Browser |
10.93 |
0.01 |
| transmembrane receptor protein serine/threonine kinase signaling pathway |
AmiGO Browser |
5.83 |
0.02 |
| regulation of B cell activation |
AmiGO Browser |
10.65 |
0.02 |
| regulation of cytokine production |
AmiGO Browser |
10.37 |
0.02 |
| leukocyte migration |
AmiGO Browser |
10.37 |
0.02 |
| transcription |
AmiGO Browser |
1.65 |
0.02 |
| regulation of protein transport |
AmiGO Browser |
10.11 |
0.02 |
| negative regulation of developmental process |
AmiGO Browser |
5.52 |
0.02 |
| hemopoiesis |
AmiGO Browser |
3.34 |
0.02 |
| leukocyte activation |
AmiGO Browser |
3.32 |
0.02 |
| positive regulation of cellular metabolic process |
AmiGO Browser |
2.63 |
0.02 |
| positive regulation of lymphocyte proliferation |
AmiGO Browser |
9.41 |
0.02 |
| positive regulation of mononuclear cell proliferation |
AmiGO Browser |
9.41 |
0.02 |
| cell communication |
AmiGO Browser |
1.47 |
0.02 |
| cell surface receptor linked signal transduction |
AmiGO Browser |
1.80 |
0.02 |
| lymphocyte mediated immunity |
AmiGO Browser |
5.23 |
0.02 |
| adaptive immune response |
AmiGO Browser |
5.10 |
0.02 |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
AmiGO Browser |
5.10 |
0.02 |
| endocrine system development |
AmiGO Browser |
8.61 |
0.02 |
| response to wounding |
AmiGO Browser |
2.53 |
0.02 |
| enzyme linked receptor protein signaling pathway |
AmiGO Browser |
2.77 |
0.02 |
| hemopoietic or lymphoid organ development |
AmiGO Browser |
3.13 |
0.02 |
| regulation of nucleocytoplasmic transport |
AmiGO Browser |
8.43 |
0.02 |
| pattern specification process |
AmiGO Browser |
3.71 |
0.02 |
| leukocyte mediated immunity |
AmiGO Browser |
4.89 |
0.02 |
| positive regulation of metabolic process |
AmiGO Browser |
2.50 |
0.02 |
| negative regulation of biological process |
AmiGO Browser |
1.79 |
0.02 |
| cell activation |
AmiGO Browser |
3.06 |
0.03 |
| cytokine and chemokine mediated signaling pathway |
AmiGO Browser |
8.09 |
0.03 |
| regulation of cell proliferation |
AmiGO Browser |
2.30 |
0.03 |
| regulation of biological process |
AmiGO Browser |
1.40 |
0.03 |
| lymphocyte differentiation |
AmiGO Browser |
4.74 |
0.03 |
| positive regulation of cell proliferation |
AmiGO Browser |
2.99 |
0.03 |
| organ development |
AmiGO Browser |
1.75 |
0.03 |
| multicellular organismal process |
AmiGO Browser |
1.45 |
0.03 |
| erythrocyte differentiation |
AmiGO Browser |
7.49 |
0.03 |
| regulation of transport |
AmiGO Browser |
4.46 |
0.03 |
| maintenance of localization |
AmiGO Browser |
7.22 |
0.03 |
| response to chemical stimulus |
AmiGO Browser |
2.35 |
0.03 |
| biological regulation |
AmiGO Browser |
1.36 |
0.03 |
| positive regulation of cytokine biosynthetic process |
AmiGO Browser |
6.97 |
0.03 |
| blood coagulation |
AmiGO Browser |
4.27 |
0.03 |
| myeloid cell differentiation |
AmiGO Browser |
4.27 |
0.03 |
| segment specification |
AmiGO Browser |
28.90 |
0.03 |
| two-component signal transduction system (phosphorelay) |
AmiGO Browser |
28.90 |
0.03 |
| immune effector process |
AmiGO Browser |
4.24 |
0.03 |
| coagulation |
AmiGO Browser |
4.18 |
0.04 |
| regulation of Ras GTPase activity |
AmiGO Browser |
6.63 |
0.04 |
| negative regulation of cellular process |
AmiGO Browser |
1.72 |
0.04 |
| regulation of lymphocyte proliferation |
AmiGO Browser |
6.52 |
0.04 |
| regulation of mononuclear cell proliferation |
AmiGO Browser |
6.52 |
0.04 |
| establishment of tissue polarity |
AmiGO Browser |
25.28 |
0.04 |
| chromosome localization |
AmiGO Browser |
25.28 |
0.04 |
| establishment of chromosome localization |
AmiGO Browser |
25.28 |
0.04 |
| hemostasis |
AmiGO Browser |
4.05 |
0.04 |
| RNA metabolic process |
AmiGO Browser |
1.49 |
0.04 |
| Notch signaling pathway |
AmiGO Browser |
6.13 |
0.04 |
| inflammatory response |
AmiGO Browser |
2.64 |
0.04 |
| positive regulation of cellular process |
AmiGO Browser |
1.77 |
0.04 |
| regulation of Rho GTPase activity |
AmiGO Browser |
22.47 |
0.04 |
| negative regulation of BMP signaling pathway |
AmiGO Browser |
22.47 |
0.04 |
| endothelial cell migration |
AmiGO Browser |
22.47 |
0.04 |
| negative regulation of small GTPase mediated signal transduction |
AmiGO Browser |
22.47 |
0.04 |
| transforming growth factor beta receptor signaling pathway |
AmiGO Browser |
6.04 |
0.04 |
| apoptosis |
AmiGO Browser |
1.88 |
0.04 |
| positive regulation of protein biosynthetic process |
AmiGO Browser |
5.86 |
0.05 |
| programmed cell death |
AmiGO Browser |
1.86 |
0.05 |
| in utero embryonic development |
AmiGO Browser |
5.78 |
0.05 |
| regulation of BMP signaling pathway |
AmiGO Browser |
20.23 |
0.05 |
| Notch receptor processing |
AmiGO Browser |
20.23 |
0.05 |
| copper ion homeostasis |
AmiGO Browser |
20.23 |
0.05 |
| immunoglobulin secretion |
AmiGO Browser |
20.23 |
0.05 |
| malate metabolic process |
AmiGO Browser |
20.23 |
0.05 |
| system development |
AmiGO Browser |
1.54 |
0.05 |
| regulation of myeloid cell differentiation |
AmiGO Browser |
5.47 |
0.05 |
| multicellular organismal development |
AmiGO Browser |
1.47 |
0.05 |
| G2/M transition checkpoint |
AmiGO Browser |
18.39 |
0.05 |
| negative regulation of cell-cell adhesion |
AmiGO Browser |
18.39 |
0.05 |
| G2/M transition DNA damage checkpoint |
AmiGO Browser |
18.39 |
0.05 |
| amyloid precursor protein catabolic process |
AmiGO Browser |
18.39 |
0.05 |
| male sex determination |
AmiGO Browser |
18.39 |
0.05 |
| negative regulation of B cell activation |
AmiGO Browser |
18.39 |
0.05 |
| positive regulation of cellular biosynthetic process |
AmiGO Browser |
5.39 |
0.05 |
| regulation of body fluids |
AmiGO Browser |
3.47 |
0.06 |
| developmental process |
AmiGO Browser |
1.38 |
0.06 |
| positive regulation of lymphocyte activation |
AmiGO Browser |
5.19 |
0.06 |
| regulation of cell-matrix adhesion |
AmiGO Browser |
16.86 |
0.06 |
| positive regulation of isotype switching |
AmiGO Browser |
16.86 |
0.06 |
| fibrinolysis |
AmiGO Browser |
16.86 |
0.06 |
| placenta development |
AmiGO Browser |
16.86 |
0.06 |
| wound healing |
AmiGO Browser |
3.43 |
0.06 |
| immune response |
AmiGO Browser |
1.93 |
0.06 |
| taxis |
AmiGO Browser |
3.39 |
0.06 |
| chemotaxis |
AmiGO Browser |
3.39 |
0.06 |
| gland development |
AmiGO Browser |
4.99 |
0.06 |
| regulation of cell-cell adhesion |
AmiGO Browser |
15.56 |
0.06 |
| regulation of DNA replication initiation |
AmiGO Browser |
15.56 |
0.06 |
| regulation of T-helper cell differentiation |
AmiGO Browser |
15.56 |
0.06 |
| leukocyte differentiation |
AmiGO Browser |
3.32 |
0.06 |
| death |
AmiGO Browser |
1.76 |
0.06 |
| cell death |
AmiGO Browser |
1.76 |
0.06 |
| Ras protein signal transduction |
AmiGO Browser |
2.64 |
0.07 |
| protein heterooligomerization |
AmiGO Browser |
14.45 |
0.07 |
| regulation of production of molecular mediator of immune response |
AmiGO Browser |
14.45 |
0.07 |
| cytokine production during immune response |
AmiGO Browser |
14.45 |
0.07 |
| regulation of cytokine production during immune response |
AmiGO Browser |
14.45 |
0.07 |
| membrane protein ectodomain proteolysis |
AmiGO Browser |
14.45 |
0.07 |
| positive regulation of transcription |
AmiGO Browser |
2.30 |
0.07 |
| I-kappaB kinase/NF-kappaB cascade |
AmiGO Browser |
3.19 |
0.07 |
| positive regulation of signal transduction |
AmiGO Browser |
3.18 |
0.07 |
| actin cytoskeleton organization and biogenesis |
AmiGO Browser |
2.58 |
0.07 |
| regulation of blood coagulation |
AmiGO Browser |
13.48 |
0.07 |
| blastocyst development |
AmiGO Browser |
13.48 |
0.07 |
| negative regulation of blood coagulation |
AmiGO Browser |
13.48 |
0.07 |
| regulation of progression through cell cycle |
AmiGO Browser |
1.85 |
0.07 |
| positive regulation of biological process |
AmiGO Browser |
1.62 |
0.07 |
| regulation of cell cycle |
AmiGO Browser |
1.84 |
0.07 |
| positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process |
AmiGO Browser |
2.25 |
0.07 |
| lymphocyte proliferation |
AmiGO Browser |
4.45 |
0.08 |
| mononuclear cell proliferation |
AmiGO Browser |
4.45 |
0.08 |
| anatomical structure development |
AmiGO Browser |
1.43 |
0.08 |
| protein maturation via proteolysis |
AmiGO Browser |
12.64 |
0.08 |
| positive regulation of biosynthetic process |
AmiGO Browser |
4.40 |
0.08 |
| rhythmic process |
AmiGO Browser |
4.30 |
0.08 |
| regulation of Ras protein signal transduction |
AmiGO Browser |
3.00 |
0.08 |
| alpha-beta T cell differentiation during immune response |
AmiGO Browser |
11.90 |
0.08 |
| protein maturation |
AmiGO Browser |
11.90 |
0.08 |
| T cell activation during immune response |
AmiGO Browser |
11.90 |
0.08 |
| CD4-positive, alpha-beta T cell differentiation during immune response |
AmiGO Browser |
11.90 |
0.08 |
| leukocyte activation during immune response |
AmiGO Browser |
11.90 |
0.08 |
| lymphocyte activation during immune response |
AmiGO Browser |
11.90 |
0.08 |
| cell activation during immune response |
AmiGO Browser |
11.90 |
0.08 |
| T cell differentiation during immune response |
AmiGO Browser |
11.90 |
0.08 |
| T-helper cell differentiation |
AmiGO Browser |
11.90 |
0.08 |
| cell differentiation |
AmiGO Browser |
1.46 |
0.08 |
| cellular developmental process |
AmiGO Browser |
1.46 |
0.08 |
| regulation of DNA binding |
AmiGO Browser |
11.24 |
0.09 |
| negative regulation of coagulation |
AmiGO Browser |
11.24 |
0.09 |
| interleukin-12 production |
AmiGO Browser |
11.24 |
0.09 |
| regulation of translation |
AmiGO Browser |
2.88 |
0.09 |
| actin filament-based process |
AmiGO Browser |
2.39 |
0.09 |
| regulation of coagulation |
AmiGO Browser |
10.65 |
0.09 |
| dicarboxylic acid metabolic process |
AmiGO Browser |
10.65 |
0.09 |
| amyloid precursor protein metabolic process |
AmiGO Browser |
10.65 |
0.09 |
| CD4-positive, alpha beta T cell differentiation |
AmiGO Browser |
10.65 |
0.09 |
| chromosome organization and biogenesis (sensu Eukaryota) |
AmiGO Browser |
2.12 |
0.09 |
| negative regulation of immune response |
AmiGO Browser |
10.11 |
0.09 |
| negative regulation of immune system process |
AmiGO Browser |
10.11 |
0.09 |
| protein targeting to ER |
AmiGO Browser |
10.11 |
0.09 |
| T-helper 2 type immune response |
AmiGO Browser |
10.11 |
0.09 |
| cotranslational protein targeting to membrane |
AmiGO Browser |
10.11 |
0.09 |
| regulation of immune effector process |
AmiGO Browser |
10.11 |
0.09 |
| beta-amyloid metabolic process |
AmiGO Browser |
10.11 |
0.09 |
| positive regulation of protein metabolic process |
AmiGO Browser |
3.82 |
0.10 |
| chromosome organization and biogenesis |
AmiGO Browser |
2.05 |
0.10 |
| regulation of cellular biosynthetic process |
AmiGO Browser |
2.70 |
0.10 |
| cell structure disassembly during apoptosis |
AmiGO Browser |
9.19 |
0.10 |
| apoptotic nuclear changes |
AmiGO Browser |
9.19 |
0.10 |
L2L Microarray Analysis Tool